SPONSOR
Guangzhou Gloria Biosciences Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1, Phase 2
Guangzhou Gloria Biosciences Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Multiple Myeloma, Solid Tumor.
The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangzhou Gloria Biosciences Co., Ltd.
How many clinical trials has Guangzhou Gloria Biosciences Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Guangzhou Gloria Biosciences Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, Solid Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangzhou Gloria Biosciences Co., Ltd. research focus on?
Guangzhou Gloria Biosciences Co., Ltd. clinical trials span Multiple Myeloma, Solid Tumor. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangzhou Gloria Biosciences Co., Ltd. clinical trial?
To participate in a Guangzhou Gloria Biosciences Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangzhou Gloria Biosciences Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Guangzhou Gloria Biosciences Co., Ltd.
NCT06514508 Phase 3
Recruiting
Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
Multiple Myeloma
NCT05909436 Phase 1, Phase 2
Recruiting
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors
Solid Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology